Corin Enters Robotic Knee Surgery Market with OMNI Orthopaedics Buy

UK International orthopedic company Corin Group, backed by the Permira funds, has signed a binding agreement for the acquisition of US-based OMNI Orthopaedics Inc., a pioneer in robotic-assisted total knee replacement.
 
It is further evidence of Permira and their co-investors’ determination to accelerate Corin’s strong organic growth with a focused M&A strategy.
 
Founded in 1999 by a team of medical device engineers, OMNI is now at the forefront of robotic-assisted knee replacement. Their OMNIBotics is a unique imageless total knee replacement solution which combines a robotic cutting guide with the world’s first robotic tool to measure ligament function. The system allows tailoring of the implant positioning to each individual patient, resulting in less patient pain and faster rehabilitation¹.  
 
Corin’s strategy is to revolutionize orthopedics by gaining, understanding and sharing insight at every stage of the joint replacement experience and delivering clinically proven implants which are optimized by unique procedural technologies. OMNIBotics, combined with APEX knee replacement, accelerates Corin’s strategy.  
 
“We are delighted to welcome the innovative and talented OMNI team into the Corin global family,” said Corin CEO Stefano Alfonsi. “We look forward to working together as a combined organization to further develop our presence in the world’s largest market—the United States. With the combination of Corin’s unique Optimised Positioning System (OPS) for the hip and the OMNIBotics platform for the knee, Corin is now uniquely positioned to address functional patient-specific joint replacement.”
 
“It is the perfect time to be part of a larger organization that shares our dedication to improving the lives of individual patients through technological innovation,” added OMNI CEO Rick Epstein. “We are thrilled to be joining Corin to maximize the potential of our robotic solutions, adding another unique technology to their ecosystem.”
 
“The US market for robotics in orthopedics is growing at a very rapid pace, and with the addition of OMNI’s technologies, we expect Corin to remain at the forefront of development in robotics and computer-assisted surgery,” commented Henry Minello, Principal in the Healthcare team of Permira We are excited about the potential to scale OMNI’s highly innovative products in the US and into other geographies where Corin operates.  We are very pleased to support Corin’s management to bring these life-changing technologies into new markets.  OMNI will also strengthen Corin’s footprint in the US, an exciting market experiencing strong technology adoption.”
 
Corin is creating a connected digital ecosystem that combines biomechanical, physiological, and logistical information to generate insight; this ecosystem will empower patients throughout their treatment journey and support surgeons to improve patient outcomes and maximize value for the healthcare system. This is Connected Orthopaedic Insight.
 
Reference
¹ Early Clinical Outcomes of a Novel Predictive Ligament Balancing Technique for Total Knee Arthroplasty